RxDoctor Payments Data

Robert Fliegelman, DO

Infectious Disease · Crestwood, ILNPI 1821084120

Payments from drug & device makers

$16in general payments, 2019–2025

Across 1 payment — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$16

What the payments were for

  • Food & beverage$16100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astellas Pharma US Inc1$16

How this compares

$16 in reported general payments places this provider in the 15th percentile of 368 infectious disease providers in Illinois.

See all infectious disease providers in Illinois

Medicare billing

Part B allowed, 2024
$638,278
Medicare patients
172
Services billed
28,997

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DovatoDolutegravir Sodium/Lamivudine14$47,488
TriumeqAbacavir/Dolutegravir/Lamivudi12$45,062
Rifampin12$199

Paid to pharmacies, not to this prescriber.

Other infectious disease in Crestwood

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →